Might of found it re 1801 anti-microbial - ”BOT is now intending...

Might of found it re 1801 anti-microbial -

”BOT is now intending to follow these results up with an expanded phase 2b clinical study. This study aims to assess how effective BTX1801 is at killing S. Aureus over a 3-month treatment period, with patients treating the nose 3 times per week.We expect this phase 2b study to be more tailored to nasal decolonization in hemodialysis patients (BOTs target indication). We conservatively anticipate the company will initiate this study in early CY’22, as a result we would expect results in the 2H’CY22.If successful we would expect the company to initiate a phase 3 study possibly later that year (CY’2022), this one likely larger and longer (at least 12 months).”

So if it started end of Q1, 3 months would be end of Q2. So results would be July or end of July at latest